Join Velsera at the Association for Molecular Pathology (AMP).
Booth 1319
Facing the growing complexity of molecular diagnostics? Whether it's streamlining your workflows, meeting regulatory demands, or ensuring diagnostic accuracy, these challenges can slow you down and impact patient care.
But it doesn’t have to be that way.
At AMP 2024, Velsera will showcase solutions designed to address these very pain points. We offer flexible tools that simplify even the most intricate processes, from oncology to pathology and genetic testing. Our cutting-edge technology enhances precision, boosts compliance, and ultimately helps you improve patient outcomes. Ready to see how Velsera can help you stay ahead in the evolving landscape of precision medicine?
Visit our booth, join our workshops, and explore our scientific posters at AMP 2024. Let us show you how we’re transforming the future of healthcare!
AMP Corporate Workshops:
Wednesday, November 20th 2024
NGS Implementation Journeys: Transforming Hospital and Academic Labs into Genomic Powerhouses!
Time: 8:00 am - 8:50 am
Room: 114 & 115, Level 1
Description: Join us in a discussion of how health system and academically-affiliated laboratories navigate the insourcing of NGS oncology testing for solid tumors and hematologic neoplasms. Velsera customers share their challenges and successes in selecting and validating assays, obtaining reimbursement, and designing clinical workflows to manage costs amid staffing uncertainty. Learn how partnering with Velsera’s experts can streamline your lab’s NGS panel validations and implementations, facilitate reimbursement by CMS and private payors, accelerate case review with CGW Plus, and offer access to other professional services pre- and post-launch of your test.
Speakers:
.svg "Headshots (1)")
Accelerating Oncology Biomarker Interpretation from NGS Panels with CGW Plus
Time: 9:00 am - 9:50 am
Room: 114 & 115, Level 1
Description: How does your laboratory determine which oncology variants merit reporting and how to tier and interpret them in the clinical report? And how do you maintain consistency across cases, while incorporating new evidence as it becomes available? These challenges demand technology solutions that help your staff focus their medical and scientific judgment where it’s needed most. In this session, we’ll showcase how Velsera’s CGW Plus solves these challenges with:
-
- A reimagined interface for variant quality assessment to focus your attention on borderline calls
- Robust workflows for rapid VUS triage, leveraging oncogenicity data and our industry-leading curated oncology Knowledgebase, for consistent application of your lab’s variant review SOPs
- Adaptive learning capabilities that remember your past reporting decisions and interpretations and highlight newly available evidence
.svg "Headshots (4)")
Scientific Posters:
Using a Knowledgebase of Clinical Assertions to Identify Potential Therapy Targets for Investigation in Underserved Cancers.
Introduction: Despite the recognized oncogenicity of certain gene alterations, many lack established therapeutic options. We leveraged the Velsera Knowledgebase (KB), which covers available associations of clinical relevance in cancer to 1250+ genes including numerous biomarker-disease-therapy associations, to identify potential molecular targets in cancer types with a paucity of therapeutic options.You'll be there too?
Let's meet!
Set up a time to meet with the Velsera team today.
Attending AMP 2024 is the perfect opportunity to discover how our platform's latest features can empower healthcare professionals to make more informed, patient-centered decisions. By scheduling a meeting with us, you’ll get an exclusive look at our expanded reporting capabilities, which offer enhanced insights while supporting the 'practice of medicine.' Our solutions streamline workflows, provide actionable data, and help navigate complex regulatory environments, making it easier to improve diagnostic and treatment outcomes.
Don't miss the chance to explore how we can help your lab stay ahead in precision medicine. Let's talk at AMP!